Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma (Q39653490)

13 September 2017

Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma (English)

1 reference

13 September 2017

Norihide Yoneda

1

1 reference

13 September 2017

Yasunori Sato

2

1 reference

13 September 2017

Azusa Kitao

3

1 reference

13 September 2017

Hiroko Ikeda

4

1 reference

13 September 2017

Seiko Sawada-Kitamura

5

1 reference

13 September 2017

Masami Miyakoshi

6

1 reference

13 September 2017

Kenichi Harada

7

1 reference

13 September 2017

Motoko Sasaki

8

1 reference

13 September 2017

Osamu Matsui

9

1 reference

13 September 2017

Yasuni Nakanuma

10

1 reference

13 September 2017

20 September 2010

1 reference

13 September 2017

Laboratory Investigation

1 reference

13 September 2017

91

1 reference

13 September 2017

2

1 reference

13 September 2017

262-272

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.161

13 September 2017

0 references

cites work

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

A decade's studies on metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Histological organization in hepatocyte organoid cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Isolation and characterization of a putative liver progenitor population after treatment of fetal rat hepatocytes with TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Involvement of signaling of VEGF and TGF-beta in differentiation of sinusoidal endothelial cells during culture of fetal rat liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Hepatocyte differentiation: from the endoderm and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Cancer stem cells--old concepts, new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Expression of biliary antigen and its clinical significance in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Diagnosis of focal nodular hyperplasia: not so easy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.161

7 January 2021

10.1038/LABINVEST.2010.161

Identifiers

DOI

1 reference

Dimensions Publication ID

13 September 2017

0 references

1 reference